Your search returned 2 results.

Results
	1.	Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study. [electronic resource] by Yuan, Zhong DeFalco, Frank Wang, Lu Hester, Laura Weaver, James Swerdel, Joel N Freedman, Amy Ryan, Patrick Schuemie, Martijn Qiu, Rose Yee, Jacqueline Meininger, Gary Berlin, Jesse A Rosenthal, Norman Producer: 20210510 In: Current medical research and opinion vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial. [electronic resource] by Jardine, Meg J Zhou, Zien Mahaffey, Kenneth W Oshima, Megumi Agarwal, Rajiv Bakris, George Bajaj, Harpreet S Bull, Scott Cannon, Christopher P Charytan, David M de Zeeuw, Dick Di Tanna, Gian Luca Greene, Tom Heerspink, Hiddo J L Levin, Adeera Neal, Bruce Pollock, Carol Qiu, Rose Sun, Tao Wheeler, David C Zhang, Hong Zinman, Bernard Rosenthal, Norman Perkovic, Vlado Producer: 20201228 In: Journal of the American Society of Nephrology : JASN vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search